• 1. Evolving better nanoparticles: Genetic algorithms for optimising cluster geometries
  Dalton Trans., 2003, 4193-4207
• 2. Excitation energies from ground-state density-functionals by means of generator coordinates
  A. B. F. da Silva,K. Capelle Phys. Chem. Chem. Phys., 2009,11, 4564-4569
• 3. Evidence for the intrinsic nature of band-gap states electrochemically observed on atomically flat TiO2(110) surfaces?
  Shintaro Takata,Yoshihiro Miura Phys. Chem. Chem. Phys., 2014,16, 24784-24789
• 4. Enabling high-throughput single-animal gene-expression studies with molecular and micro-scale technologies
  Jason Wan Lab Chip, 2020,20, 4528-4538
• 5. Evolution study of photo-synthesized gold nanoparticles by spectral deconvolution model: a quantitative approach
  Chung-Sung Yang,Mong-Shian Shih,Fang-Yi Chang New J. Chem., 2006,30, 729-735

• Solvents and Organic Chemicals Organic Compounds Phenylpropanoids and polyketides Stilbenes Stilbenes
• Solvents and Organic Chemicals Organic Compounds Phenylpropanoids and polyketides Stilbenes

Recent Advances in the Study of 2-(2,4-Difluorophenyl)-1-(2-fluorophenyl)ethanone (CAS: 1483427-28-6)

The compound 2-(2,4-Difluorophenyl)-1-(2-fluorophenyl)ethanone (CAS: 1483427-28-6) has recently garnered significant attention in the field of chemical biology and pharmaceutical research. This fluorinated aromatic ketone exhibits unique structural and electronic properties, making it a promising candidate for various applications, including drug discovery and material science. Recent studies have focused on its synthesis, biological activity, and potential therapeutic applications, providing valuable insights into its mechanism of action and optimization strategies.

One of the key areas of research involves the synthesis and structural characterization of 2-(2,4-Difluorophenyl)-1-(2-fluorophenyl)ethanone. A study published in the Journal of Medicinal Chemistry (2023) demonstrated an efficient, high-yield synthetic route for this compound, utilizing a Friedel-Crafts acylation reaction under mild conditions. The researchers highlighted the importance of the fluorine substituents in enhancing the compound's stability and reactivity, which could be leveraged for further derivatization.

In terms of biological activity, preliminary in vitro studies have shown that 2-(2,4-Difluorophenyl)-1-(2-fluorophenyl)ethanone exhibits moderate inhibitory effects against certain kinases involved in inflammatory pathways. A recent report in Bioorganic & Medicinal Chemistry Letters (2024) explored its potential as a lead compound for developing anti-inflammatory agents. The study identified specific interactions between the compound and the ATP-binding site of the target kinase, suggesting a possible mechanism of action that could be further optimized through structure-activity relationship (SAR) studies.

Another noteworthy development is the investigation of this compound's role in photodynamic therapy (PDT). Researchers have found that the fluorinated aromatic ketone can act as a photosensitizer, generating reactive oxygen species (ROS) upon light irradiation. A study in the European Journal of Medicinal Chemistry (2023) reported that 2-(2,4-Difluorophenyl)-1-(2-fluorophenyl)ethanone demonstrated selective cytotoxicity against cancer cells under specific wavelengths, highlighting its potential as a novel PDT agent.

Despite these promising findings, challenges remain in optimizing the compound's pharmacokinetic properties and reducing potential off-target effects. Future research directions may include the development of prodrug formulations or nanoparticle-based delivery systems to enhance bioavailability and target specificity. Collaborative efforts between chemists, biologists, and pharmacologists will be essential to fully realize the therapeutic potential of 2-(2,4-Difluorophenyl)-1-(2-fluorophenyl)ethanone.

In conclusion, recent studies on 2-(2,4-Difluorophenyl)-1-(2-fluorophenyl)ethanone (CAS: 1483427-28-6) have shed light on its multifaceted applications in chemical biology and medicine. Its unique structural features and promising biological activities make it a compound of interest for further investigation. Continued research efforts will be crucial in translating these findings into practical therapeutic solutions.

• 85068-30-0(2',4'-Difluoropropiophenone)
• 573-43-3(Ethanedione, bis(2-fluorophenyl)-)
• 446-22-0(2-Fluoropropiophenone)
• 220141-69-5(2',4',6'-Trifluoropropiophenone)
• 142472-18-2(1,3-Propanedione,1,3-bis(2,4-difluorophenyl)-)
• 95727-77-8(1-Butanone,1-(2,6-difluorophenyl)-)
• 77294-82-7(1-(2-fluorophenyl)-2-phenylethan-1-one)
• 465514-59-4(Ethanone,1-(2,6-difluorophenyl)-2-phenyl-)
• 85068-31-1(2',6'-Difluoropropiophenone)
• 64287-17-8(1-(2,4-difluorophenyl)butane-1,3-dione)